The hypertension optimal treatment trial: A precursor for lowering the target blood pressure level C. Venkata S. Ram Invited Commentary Pages: 195 - 196
Isolated systolic hypertension, pulse pressure, and arterial stiffness as risk factors for cardiovascular disease Michael F. O’Rourke OriginalPaper Pages: 204 - 211
Carcinogenicity of cardiovascular drugs Ehud GrossmanFranz H. MesserliUri Goldbourt OriginalPaper Pages: 212 - 218
Relevance of heart rate as a risk factor in hypertension Paolo PalatiniStevo Julius OriginalPaper Pages: 219 - 224
Treatment of diabetic patients with hypertension Willem H. BirkenhägerJan A. Staessen OriginalPaper Pages: 225 - 231
Effects of hypertension and its treatment on mental function Marie-Laure SeuxFrançoise Forette OriginalPaper Pages: 232 - 237
Recent outcome trials of newer antihypertensives Stephen BakirSuzanne Oparil Clinical Trials Review Pages: 238 - 240
The role of the central nervous system in hypertension J. Michael WyssScott H. Carlson OriginalPaper Pages: 246 - 253
The sympathetic nervous system and baroreflexes in hypertension and hypotension Joseph L. Izzo Jr.Addison A. Taylor OriginalPaper Pages: 254 - 263
Brainstem compression as a cause of neurogenic hypertension Michael B. Horowitz OriginalPaper Pages: 264 - 267
Obstructive sleep apnea as a cause of neurogenic hypertension Krzysztof NarkiewiczVirend K. Somers OriginalPaper Pages: 268 - 273